Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
NASDAQ:MREO
Price:
3.005 USD
-0.17%
Updated:
May 8, 2024
Mereo Biopharma Group PLC
Interest Income Expense
|
Mereo Biopharma Group PLC
Interest Income Expense Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Interest Income Expense
£7.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Interest Income Expense
$570k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Interest Income Expense
-$29m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Interest Income Expense
$13.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
126%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Interest Income Expense
-£344k
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Interest Income Expense
-£10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-102%
|
CAGR 10-Years
-20%
|
See Also
What is Mereo Biopharma Group PLC's Interest Income Expense?
Interest Income Expense
7.2m
GBP
7.2m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Interest Income Expense amounts to 7.2m GBP.
What is Mereo Biopharma Group PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-80%
-80%
Over the last year, the Interest Income Expense growth was -80%.
You don't have any saved screeners yet
